US Stock MarketDetailed Quotes

HUM Humana

Watchlist
  • 253.830
  • +0.950+0.38%
Close Feb 14 16:00 ET
  • 250.500
  • -3.330-1.31%
Post 20:01 ET
30.62BMarket Cap25.43P/E (TTM)

About Humana Company

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Company Profile

SymbolHUM
Company NameHumana
Listing DateMay 18, 1971
Founded1961
CEOMr. James A. Rechtin
MarketNYSE
Employees67600
Fiscal Year Ends12-31
Address500 West Main Street
CityLouisville
ProvinceKentucky
CountryUnited States of America
Zip Code40202
Phone1-502-580-1000

Company Executives

  • Name
  • Position
  • Salary
  • James A. Rechtin
  • Director, President and Chief Executive Officer
  • --
  • Timothy S. Huval
  • Chief Administrative Officer
  • --
  • Vishal Agrawal
  • Chief Strategy and Corporate Development Officer
  • --
  • Joseph C. Ventura
  • Chief Legal Officer
  • 3.10M
  • Samir Deshpande
  • Chief Information Officer
  • --
  • John-Paul W. Felter
  • Senior Vice President, Chief Accounting Officer and Controller
  • --
  • Dr. William Kevin Fleming, Pharm.D.
  • Chief Corporate Affairs Officer
  • --
  • George II Renaudin
  • President, Medicare and Medicaid
  • 3.05M
  • Dr. Sanjay K. Shetty
  • President, CenterWell
  • 4.58M
  • Kurt J. Hilzinger
  • Chairman of the Board
  • 601.30K
  • Karen W. Katz
  • Independent Director
  • 219.97K
  • Marcy S. Klevorn
  • Independent Director
  • 351.94K
  • Brad D. Smith
  • Independent Director
  • 311.07K
  • Frank A. D'Amelio
  • Independent Director
  • 363.55K
  • Dr. Raquel C. Bono, M.D.
  • Independent Director
  • 345.03K
  • Gordon A. Smith
  • Independent Director
  • --
  • Dr. David T. Feinberg, M.D.,PhD
  • Independent Director
  • 321.52K
  • Dr. Wayne A.I. Frederick, M.D.
  • Independent Director
  • 364.87K
  • Jorge S. Mesquita
  • Independent Director
  • 351.59K
  • John W. Garratt
  • Independent Director
  • 326.03K

Trending Stocks

Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More